Open AccessHow Introducing a Registry With Automated Alerts for Carbapenem-resistant Enterobacteriaceae (CRE) May Help Control CRE Spread in a Region
Author(s) -
Bruce Y. Lee,
Sarah M. Bartsch,
Mary K. Hayden,
Joel Welling,
Jay V. DePasse,
Sarah K. Kemble,
Jim Leonard,
Robert A. Weinstein,
Leslie E. Mueller,
Kruti Doshi,
Shawn T. Brown,
William Trick,
Michael Lin
Publication year - 2019
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz300
Subject(s) - medicine , carbapenem resistant enterobacteriaceae , infection control , acute care , metropolitan area , emergency medicine , medical emergency , health care , intensive care medicine , enterobacteriaceae , pathology , biochemistry , chemistry , escherichia coli , economics , gene , economic growth
Regions are considering the use of electronic registries to track patients who carry antibiotic-resistant bacteria, including carbapenem-resistant Enterobacteriaceae (CRE). Implementing such a registry can be challenging and requires time, effort, and resources; therefore, there is a need to better understand the potential impact.